Cited by 170

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Tumour suppression by p53: the importance of apoptosis and cellular senescence

Zuckerman, Valentina, Wolyniec, Kamil, Sionov, Ronit V, Haupt, Sue, Haupt, Ygal·2009·The Journal of Pathology

Open this paper in CoChat — free account

Abstract

p53 is regarded as a central player in tumour suppression, as it controls programmed cell death (apoptosis) as well as cellular senescence. While apoptosis eliminates cells at high risk for oncogenic transformation, senescence acts as a barrier to tumourigenesis by imposing irreversible cell cycle arrest. p53 can act directly or indirectly at multiple levels of the tumour suppression network by invoking a myriad of mechanisms. p53 induces the extrinsic and intrinsic apoptotic pathways at multiple steps to ensure an efficient death response. This response involves transcriptional activation or repression of target genes, as well as the recently identified microRNAs, and transcription‐independent functions. Importantly, p53 loss of function is required for tumour maintenance. Therefore, therapeutic strategies aimed at reactivation of p53 in tumours emerge as a promising approach for the treatment of cancer patients. Copyright © 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/path.2584

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 3×
“Notably, it seems that certain oncogenes, such as Myc, preferentially induce ARF–p53-dependent apoptosis, whereas Ras is a prototypical mediator of senescence in primary fibroblasts [62,89].”
Background
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917 · cited 1×
“It is conjectured that telomere erosion beyond a certain limit triggers a DNA damage response and subsequent activation of the ATM/ATR–p53 pathway, resulting in growth arrest [11,12].”
Background
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921
Restoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820 · cited 3×
“Interestingly, restoration of p53 in two types of solid tumour, radiation-induced sarcomas and hepatocellular carcinoma, led to cellular senescence and tumour clearance [105,106].”
Background
Telomere Shortening Triggers Senescence of Human Cells through a Pathway Involving ATM, p53, and p21CIP1, but Not p16INK4a
Herbig, U., Jobling, W. A., Chen, B. P. C., Chen, D. J., & Sedivy, J. M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00256-4 · Cited by 1,344 · cited 1×
“It is conjectured that telomere erosion beyond a certain limit triggers a DNA damage response and subsequent activation of the ATM/ATR–p53 pathway, resulting in growth arrest [11,12].”
Background
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Apoptosis - the p53 network
Haupt, S., Berger, M., Goldberg, Z., & Haupt, Y. (2003) · Journal of Cell Science · doi:10.1242/jcs.00739 · Cited by 1,136
Self-citation
Cytoplasmic functions of the tumour suppressor p53
Green, D. R., & Kroemer, G. (2009) · Nature · doi:10.1038/nature07986 · Cited by 1,106
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
Bykov, V. J. N., Issaeva, N., Shilov, A., Hultcrantz, M., Pugacheva, E., Chumakov, P., Bergman, J., Wiman, K. G., & Selivanova, G. (2002) · Nature Medicine · doi:10.1038/nm0302-282 · Cited by 1,067
14-3-3σ is required to prevent mitotic catastrophe after DNA damage
Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Nature · doi:10.1038/44188 · Cited by 895
Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all
Gil, J., & Peters, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1987 · Cited by 843
p53 isoforms can regulate p53 transcriptional activity
Bourdon, J.-C., Fernandes, K., Murray-Zmijewski, F., Liu, G., Diot, A., Xirodimas, D. P., Saville, M. K., & Lane, D. P. (2005) · Genes & Development · doi:10.1101/gad.1339905 · Cited by 810
Acetylation of the p53 DNA-binding domain regulates apoptosis induction.
Sykes, S. M., Mellert, H. S., Holbert, M. A., Li, K., Marmorstein, R., Lane, W. S., & McMahon, S. B. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.11.026 · Cited by 752
Cellular Senescence
Sherr, C. J., & DePinho, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)00046-5 · Cited by 745
The complexity of p53 stabilization and activation
Lavin, M. F., & Gueven, N. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401925 · Cited by 701
Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence
Kortlever, R. M., Higgins, P. J., & Bernards, R. (2006) · Nature Cell Biology · doi:10.1038/ncb1448 · Cited by 637 · cited 1×
“Importantly, downregulation of PAI-1 results in escape from replicative senescence in murine and human primary fibroblasts, through sustained activation of the PI3K–Akt survival pathway and nuclear retention of Cyclin D [63].”
Background
Modeling the Therapeutic Efficacy of p53 Restoration in Tumors
Martins, C. P., Brown-Swigart, L., & Evan, G. I. (2006) · Cell · doi:10.1016/j.cell.2006.12.007 · Cited by 600 · cited 2×
“Martins et al [103] demonstrated that restoring p53 function in p53-deficient Eμmyc-driven lymphomas triggered a rapid and extensive cell death [103].”
Background
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
Sage, J., Miller, A. L., Pérez-Mancera, P. A., Wysocki, J. M., & Jacks, T. (2003) · Nature · doi:10.1038/nature01764 · Cited by 538
Hallmarks of senescence in carcinogenesis and cancer therapy
Shay, J. W., & Roninson, I. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207518 · Cited by 502
Different telomere damage signaling pathways in human and mouse cells
Smogorzewska, A., & de Lange, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf433 · Cited by 482 · cited 1×
“In human cells, however, inactivation of both p53 and pRb is essential to prevent the onset of replicative senescence, whereas disruption of only one of these pathways only delays the onset of senescence [26].”
Background
Escape from Therapy-Induced Accelerated Cellular Senescence in p53-Null Lung Cancer Cells and in Human Lung Cancers
Roberson, R. S., Kussick, S. J., Vallieres, E., Chen, S.-Y. J., & Wu, D. Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1270 · Cited by 428
Ablation of the Retinoblastoma gene family deregulates G1 control causing immortalization and increased cell turnover under growth-restricting conditions
Dannenberg, J.-H., van Rossum, A., Schuijff, L., & te Riele, H. (2000) · Genes & Development · doi:10.1101/gad.847700 · Cited by 413
The pathological response to DNA damage does not contribute to p53-mediated tumour suppression
Christophorou, M. A., Ringshausen, I., Finch, A. J., Swigart, L. B., & Evan, G. I. (2006) · Nature · doi:10.1038/nature05077 · Cited by 382
PRAK Is Essential for ras-Induced Senescence and Tumor Suppression
Sun, P., Yoshizuka, N., New, L., Moser, B. A., Li, Y., Liao, R., Xie, C., Chen, J., Deng, Q., Yamout, M., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.050 · Cited by 321
Dysfunctional telomeres activate an ATM‐ATR‐dependent DNA damage response to suppress tumorigenesis
Guo, X., Deng, Y., Lin, Y., Cosme‐Blanco, W., Chan, S., He, H., Yuan, G., Brown, E. J., & Chang, S. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601893 · Cited by 258
PRIMA-1MET synergizes with cisplatin to induce tumor cell apoptosis
Bykov, V. J. N., Zache, N., Stridh, H., Westman, J., Bergman, J., Selivanova, G., & Wiman, K. G. (2005) · Oncogene · doi:10.1038/sj.onc.1208419 · Cited by 252
The differential impact of p16INK4a or p19ARF deficiency on cell growth and tumorigenesis
Sharpless, N. E., Ramsey, M. R., Balasubramanian, P., Castrillon, D. H., & DePinho, R. A. (2004) · Oncogene · doi:10.1038/sj.onc.1207074 · Cited by 224 · cited 7×
“Intriguingly, chemical inhibition of histone deacetylase, resulting in chromatin decondensation and the formation of euchromatin, was also found to cause p53-mediated senescence in MEFs [38].”
BackgroundInfluential
INK4a‐deficient human diploid fibroblasts are resistant to RAS‐induced senescence
Brookes, S., Rowe, J., Ruas, M., Llanos, S., Clark, P. A., Lomax, M., James, M. C., Vatcheva, R., Bates, S., Vousden, K. H., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf289 · Cited by 220
Role of p14ARF in Replicative and Induced Senescence of Human Fibroblasts
Wei, W., Hemmer, R. M., & Sedivy, J. M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.20.6748-6757.2001 · Cited by 217
Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53‐dependent cellular senescence
Cosme‐Blanco, W., Shen, M., Lazar, A. J. F., Pathak, S., Lozano, G., Multani, A. S., & Chang, S. (2007) · The EMBO Reports · doi:10.1038/sj.embor.7400937 · Cited by 205
HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function
Lau, L. M. S., Nugent, J. K., Zhao, X., & Irwin, M. S. (2008) · Oncogene · doi:10.1038/sj.onc.1210707 · Cited by 182
Tissue-specific and reversible RNA interference in transgenic mice
Dickins, R. A., McJunkin, K., Hernando, E., Premsrirut, P. K., Krizhanovsky, V., Burgess, D. J., Kim, S. Y., Cordon-Cardo, C., Zender, L., Hannon, G. J., et al. (2007) · Nature Genetics · doi:10.1038/ng2045 · Cited by 174
Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1
Ambrosini, G., Sambol, E. B., Carvajal, D., Vassilev, L. T., Singer, S., & Schwartz, G. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210136 · Cited by 163
Cancer-derived p53 mutants suppress p53-target gene expression--potential mechanism for gain of function of mutant p53
Vikhanskaya, F., Lee, M. K., Mazzoletti, M., Broggini, M., & Sabapathy, K. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm099 · Cited by 145
Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock
Munro, J., Barr, N. I., Ireland, H., Morrison, V., & Parkinson, E. K. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.017 · Cited by 141
Identification of Cell Cycle Regulatory Genes as Principal Targets of p53-mediated Transcriptional Repression
Spurgers, K. B., Gold, D. L., Coombes, K. R., Bohnenstiehl, N. L., Mullins, B., Meyn, R. E., Logothetis, C. J., & McDonnell, T. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513901200 · Cited by 114
p53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosis
Kawase, T., Ichikawa, H., Ohta, T., Nozaki, N., Tashiro, F., Ohki, R., & Taya, Y. (2008) · Oncogene · doi:10.1038/onc.2008.32 · Cited by 105

Research works printed but not linked: 102

10.1038/nature03098 · DOI · Paper page
10.1016/S0092-8674(04)01252-8 · DOI · Paper page
10.1038/sj.cdd.4401913 · DOI · Paper page
10.1038/sj.onc.1202314 · DOI · Paper page
10.1016/j.cell.2004.11.006 · DOI · Paper page
10.1038/nrm2147 · DOI · Paper page
10.1016/S0959-437X(99)00047-7 · DOI · Paper page
10.1016/j.ccr.2007.02.026 · DOI · Paper page
10.1126/science.1116801 · DOI · Paper page
10.1016/j.tcb.2007.07.012 · DOI
10.1038/ncb1024 · DOI · Paper page
10.1016/S0959-437X(01)00271-4 · DOI
10.1016/j.ccr.2005.05.025 · DOI · Paper page
Harvey M, 1993, In vitro growth characteristics of embryo fibroblasts isolated from p53‐deficient mice, Oncogene, 8, 2457
10.1016/S1097-2765(00)80264-6 · DOI · Paper page
10.1038/sj.onc.1206439 · DOI
Roninson IB, 2003, Tumor cell senescence in cancer treatment, Cancer Res, 63, 2705
10.1128/MCB.22.10.3497-3508.2002 · DOI · Paper page
10.1128/MCB.20.1.273-285.2000 · DOI · Paper page
10.1038/sj.onc.1207729 · DOI
10.1038/onc.2009.101 · DOI
10.1042/bj3320043 · DOI · Paper page
10.1016/j.febslet.2007.05.036 · DOI
10.4161/cc.2.2.337 · DOI
10.1101/gad.14.16.2015 · DOI · Paper page
10.1038/35018127 · DOI · Paper page
10.1016/S1097-2765(04)00062-0 · DOI · Paper page
10.1038/sj.cdd.4401910 · DOI · Paper page
10.1126/science.277.5331.1501 · DOI · Paper page
10.1074/jbc.M000284200 · DOI · Paper page
10.1038/sj.onc.1202667 · DOI · Paper page
10.1038/sj.onc.1209989 · DOI
10.1016/j.molcel.2004.11.002 · DOI · Paper page
10.1111/j.1582-4934.2008.00616.x · DOI
10.1038/sj.emboj.7600769 · DOI
10.1038/sj.onc.1210148 · DOI
10.1074/jbc.M710268200 · DOI
10.1002/jcp.1041650324 · DOI
10.1038/sj.cdd.4401908 · DOI · Paper page
10.2174/156800908783769337 · DOI · Paper page
10.1016/j.bbabio.2008.10.005 · DOI · Paper page
10.1128/MCB.00738-07 · DOI
10.1074/jbc.M802940200 · DOI · Paper page
10.1128/MCB.00959-05 · DOI
10.4161/cbt.7.12.7460 · DOI
Maecker HL, 2000, p53 promotes selection for Fas‐mediated apoptotic resistance, Cancer Res, 60, 4638
10.1038/38525 · DOI · Paper page
10.1016/j.ceb.2005.09.007 · DOI · Paper page
10.1074/jbc.275.21.16202 · DOI · Paper page
10.1016/S1097-2765(03)00050-9 · DOI · Paper page
10.1038/sj.onc.1209641 · DOI
10.1158/0008-5472.CAN-05-1084 · DOI
10.1128/MCB.24.15.6728-6741.2004 · DOI · Paper page
10.1038/ng1093 · DOI · Paper page
10.1038/nrc2232 · DOI · Paper page
10.1016/j.ccr.2007.10.028 · DOI · Paper page
10.1158/0008-5472.CAN-05-3830 · DOI · Paper page
10.1038/sj.cdd.4402083 · DOI
10.1038/ng2003 · DOI · Paper page
10.1038/onc.2008.37 · DOI
10.4161/cc.7.2.5236 · DOI
10.1016/j.molcel.2006.11.021 · DOI · Paper page
10.1093/emboj/18.23.6845 · DOI · Paper page
10.1038/ncb714 · DOI · Paper page
10.4161/cc.5.23.3526 · DOI
10.1016/j.molcel.2007.02.007 · DOI · Paper page
10.1038/nsmb1306 · DOI
10.1083/jcb.200512059 · DOI · Paper page
10.1016/j.cell.2006.09.031 · DOI · Paper page
10.1158/0008-5472.CAN-08-0865 · DOI
10.1038/443159a · DOI
10.1016/j.cell.2007.02.022 · DOI
10.1038/sj.bjc.6604098 · DOI
10.1097/01.cad.0000217422.52208.fa · DOI
10.1016/S0076-6879(05)99041-1 · DOI
10.1074/jbc.M410233200 · DOI · Paper page
10.1038/nature05194 · DOI · Paper page
10.1158/0008-5472.CAN-07-0200 · DOI · Paper page
10.1158/0008-5472.CAN-07-2780 · DOI · Paper page
10.1158/1541-7786.MCR-07-0161 · DOI
10.1158/0008-5472.CAN-06-2710 · DOI · Paper page
10.4161/cc.8.11.8596 · DOI
10.1038/nm1146 · DOI · Paper page
10.1186/1742-4682-2-38 · DOI
10.1038/sj.cdd.4402301 · DOI
10.1126/science.286.5449.2507 · DOI · Paper page
10.1128/MCB.23.6.2171-2181.2003 · DOI · Paper page
10.1073/pnas.0604507103 · DOI
10.1172/JCI32481 · DOI · Paper page
10.1016/S1535-6108(03)00078-3 · DOI · Paper page
10.1073/pnas.0802091105 · DOI · Paper page
10.1172/JCI28920 · DOI
10.1016/S0065-2660(05)54010-0 · DOI
10.1089/hum.2005.16.1016 · DOI · Paper page
10.1038/cgt.2008.69 · DOI · Paper page
10.1215/15228517-2008-015 · DOI
10.1158/1535-7163.MCT-07-0395 · DOI
10.4161/cc.7.16.6070 · DOI
10.4161/cbt.5.11.3300 · doi:10.4161/cbt.5.11.3300
10.1016/j.cell.2005.04.032 · DOI
10.1101/gad.1162404 · DOI · Paper page
10.1016/j.ejca.2006.10.019 · DOI

Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice
Kong, X., Feng, D., Wang, H., Hong, F., Bertola, A., Wang, F.-S., & Gao, B. (2012) · Hepatology · doi:10.1002/hep.25744 · Cited by 448
Programmed cell death in aging
Tower, J. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.04.002 · Cited by 426
MicroRNAs in apoptosis, autophagy and necroptosis
Su, Z., Yang, Z., Xu, Y., Chen, Y., & Yu, Q. (2015) · Oncotarget · doi:10.18632/oncotarget.3523 · Cited by 342
MicroRNA regulation of core apoptosis pathways in cancer
Lima, R. T., Busacca, S., Almeida, G. M., Gaudino, G., Fennell, D. A., & Vasconcelos, M. H. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.11.005 · Cited by 260

See all 170

Authors: Zuckerman, V., Wolyniec, K., Sionov, R. V., Haupt, S., & Haupt, Y.
Venue: The Journal of Pathology
Publisher: Wiley
Published: 2009-06-26
Volume: 219
Issue: 1
Pages: 3-15
ISSN: 0022-3417
1096-9896
DOI: 10.1002/path.2584
Cited by: 170
References: 43
Language: en
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Tumour suppression by p53: the importance of apoptosis and cellular senescence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources